Azenta Inc (AZTA) USD0.01

Sell:$36.40Buy:$36.48$1.79 (4.69%)

NASDAQ:1.53%
Prices delayed by at least 15 minutes
Sell:$36.40
Buy:$36.48
Change:$1.79 (4.69%)
Deal now
Prices delayed by at least 15 minutes
Sell:$36.40
Buy:$36.48
Change:$1.79 (4.69%)
Prices delayed by at least 15 minutes
Deal now

Company Information

About this company

Azenta, Inc. is a provider of life sciences solutions worldwide. The Company provides a full suite of cold-chain sample management solutions and multiomics services across areas such as drug development, clinical research and advanced cell therapies for pharmaceutical, biotech, academic and healthcare institutions globally. The Company's segments include Sample Management Solutions and Multiomics. Its Sample Management Solutions segment offers end-to-end sample management products and services, including sample repository services and core products (automated stores, cryogenic systems, automated sample tube, consumables and instruments and controlled rate thawing devices). The Company's Multiomics segment includes its genomic services business, which advances research and development activities by providing gene sequencing, synthesis, editing and related services. The Company's brands include GENEWIZ, FluidX, Ziath, 4titude, Limfinity, Freezer Pro, and Barkey.

Key people

John Marotta
President, Chief Executive Officer, Director
Lawrence Y Lin
Chief Financial Officer, Executive Vice President
Olga Pirogova
Chief Human Resource Officer, Senior Vice President
Jason W. Joseph
Senior Vice President, General Counsel, Secretary
Ginger Zhou
Senior Vice President, General Manager - Multi-Omics
David Wang
Senior Vice President and General Manager, Sample Management Solutions
Violetta Hughes
Chief Accounting Officer, Vice President and Principal Accounting Officer
Frank E. Casal
Independent Chairman of the Board
Dipal Doshi
Director
William L. Cornog
Independent Director
Robyn C. Davis
Independent Director
Quentin Koffey
Independent Director
Click to see more

Key facts

  • EPIC
    AZTA
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    US1143401024
  • Market cap
    $1.86bn
  • Employees
    3,000
  • Shares in issue
    59.16m
  • Exchange
    NASDAQ
  • Index
    S&P 600 Small Cap, TR Equity United States Index
  • Website
    Visit website

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.